<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-18T23:15:06Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/14933" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/14933</identifier><datestamp>2026-10-18T20:43:06Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Design, synthesis and cytotoxic evaluation of β-aryl-α-dimethoxyphosphoryl-γ-lactams</dc:title><dc:creator>Cinar, Seda</dc:creator><dc:creator>Unaleroglu, Canan</dc:creator><dc:creator>Ak, Ayşe</dc:creator><dc:creator>Garipcan, Bora</dc:creator><dc:subject>Chemotherapeutic drugs</dc:subject><dc:subject>In vitro cytotoxic activity</dc:subject><dc:subject>Nitrovinyl arenes</dc:subject><dc:subject>β-Aryl-α-dimethoxyphosphoryl-γ-lactams</dc:subject><dc:subject>beta aryl alpha dimethoxyphosphoryl gamma lactam derivative</dc:subject><dc:subject>cytotoxic agent</dc:subject><dc:subject>dimethyl [2 oxo 4 (thiophen 2 yl)pyrrolidin 3 yl]phosphonate</dc:subject><dc:subject>dimethyl [4 (furan 2 yl) 2 oxopyrrolidin 3 yl]phosphonate</dc:subject><dc:subject>gamma lactam derivative</dc:subject><dc:subject>methyl 2 (dimethoxyphosphoryl) 3 (furan 2 yl) 4 nitrobutanoate</dc:subject><dc:subject>methyl 2 (dimethoxyphosphoryl) 4 nitro 3 (thiophen 2 yl) butanoate</dc:subject><dc:subject>unclassified drug</dc:subject><dc:subject>addition reaction</dc:subject><dc:subject>Article</dc:subject><dc:subject>cell viability</dc:subject><dc:subject>cytotoxicity</dc:subject><dc:subject>drug design</dc:subject><dc:subject>drug screening</dc:subject><dc:subject>drug synthesis</dc:subject><dc:subject>glioblastoma cell line</dc:subject><dc:subject>human</dc:subject><dc:subject>human cell</dc:subject><dc:subject>IC50</dc:subject><dc:subject>in vitro study</dc:subject><dc:subject>L929 cell line</dc:subject><dc:subject>MCF-7 cell line</dc:subject><dc:subject>Michael addition</dc:subject><dc:subject>neuroblastoma cell line</dc:subject><dc:subject>prostate cancer cell line</dc:subject><dc:subject>proton nuclear magnetic resonance</dc:subject><dc:description>New β-aryl-α-dimethoxyphosphoryl-γ-lactams 4a, b were designed and synthesized through the intra-molecular cyclization of 3a, b obtained from the addition reaction of methyl 2-(dimethoxyphosphoryl)acetate to (E)-2-(2-nitrovinyl)thiophene and (E)-2-(2-nitrovinyl)furan, respectively. The in vitro cytotoxicity of these compounds was evaluated against human breast cancer (MCF-7), rat glioblastoma (C6), prostate cancer (PC3), neuroblastoma (SHSY-5Y), and mouse fibroblast cell lines (L929). Dimethyl (4-(furan-2-yl)-2-oxopyrrolidin-3-yl)phosphonate (4b) was found to have cytotoxic activity towards MCF-7 and PC3 cell lines at the concentration values above 5 mM and 6 mM, respectively (IC50 values of MCF-7, 5.92 ± 1.86; PC3, 6.70 ± 2.10 mM). Dimethyl (2-oxo-4-(thiophen-2-yl)pyrrolidin-3-yl)phosphonate (4a) only decreased the viability of MCF-7 cells at 8 mM concentration (IC50 value of MCF-7 5.67 ± 1.70 in mM). In addition 4a, b had shown no significant cytotoxic effect on C6, SHSY-5Y and L929 cell lines. © 2017, Springer Science+Business Media New York.</dc:description><dc:publisher>Birkhauser Boston</dc:publisher><dc:date>2017</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/14933</dc:identifier><dc:identifier>https://doi.org/10.1007/s00044-017-1816-y</dc:identifier><dc:identifier>1054-2523</dc:identifier><dc:language>en</dc:language><dc:relation>Medicinal Chemistry Research</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/14933</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>